2019
DOI: 10.20902/ijctr.2019.120613
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of Chromium (III)Picolinate in Capsule dosage form by using Stability indicating HPTLC Method

Abstract: Chromium (III) picolinate is used as a nutritional supplement and has been valuable effects on carbohydrate and lipid metabolism alleviating symptoms associated with diabetes. A chromium supplement produces beneficial results in reducing insulin sulfonylurea or metformin requirements. Hence, stability indicating HPTLC method was developed for estimation of Chromium picolinate in capsule formulation. The development of HPTLC method optimization on precoated silica gel 60 F254 aluminium plates of 20 cm x 20 cm, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
1
0
0
Order By: Relevance
“…Similarly, our findings regarding the stability of chromium picolinate as judged from the level of chromium, demonstrated it to be stable for the whole period of the study in the three dosage forms under the accelerated stability study conditions. This finding agreed with multiple previous studies that showed that chromium-picolinate is a highly stable molecule with an over 95% recovery under forced degradation [68,69].…”
Section: Discussionsupporting
confidence: 93%
“…Similarly, our findings regarding the stability of chromium picolinate as judged from the level of chromium, demonstrated it to be stable for the whole period of the study in the three dosage forms under the accelerated stability study conditions. This finding agreed with multiple previous studies that showed that chromium-picolinate is a highly stable molecule with an over 95% recovery under forced degradation [68,69].…”
Section: Discussionsupporting
confidence: 93%